Date of management change: January 17, 2009
Newton, MA-based Pro Pharmaceuticals, Inc. appointed David Platt as Chief Technology Officer.
DAVANAT, the Company's lead product candidate, is a targeted therapeutic compound composed of a complex carbohydrate polymer. DAVANAT's mechanism of action is targeting lectins on the tumor cell surface.
David Platt was previously the CEO and President of Pro-Pharmaceuticals.
Press Release
Short ProfileName: David Platt
Title: Chief Technology Officer
Company: Pro Pharmaceuticals, Inc.
Industry: Business Services Other
Current Contact InfoEmail: *****@pro-pharmaceuticals.com
Phone:.***.***.*03*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Salian Nick, Tan Stephanie, Wilkerson David, Demeria Sara, Lurie Brian, Lewis Starnes Courtney, Gao Jason, D`Hers Thierry, Hammer Alice, Kirkpatrick Tom, Vandanapu Vismayie
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
